Rhabdomyolysis
Rhabdomyolysis is a syndrome of acute skeletal muscle breakdown resulting in release of intracellular contents into the circulation. Although it originates in muscle tissue, its consequences are systemic, affecting renal function, electrolyte balance, acid–base status, and cardiovascular stability. Understanding the pathophysiology explains why rhabdomyolysis can progress rapidly from local muscle injury to life-threatening complications, and why early recognition and intervention are critical.
What You Need to Know
Rhabdomyolysis develops when skeletal muscle cells are injured to the point that they can no longer maintain membrane integrity. Under normal conditions, muscle fibres rely on a continuous supply of adenosine triphosphate to preserve ion gradients and structural stability. When energy production fails, due to trauma, prolonged compression, extreme exertion, hyperthermia, ischaemia, or toxic injury, cell membranes become permeable and eventually rupture.
Loss of membrane integrity allows large quantities of intracellular contents to escape into the circulation. These substances are normally confined within muscle cells and tightly regulated. Once released systemically, they disrupt electrolyte balance, acid–base status, and renal function, producing effects that extend far beyond the injured muscle itself.
Several key intracellular components drive the systemic consequences of rhabdomyolysis:
Myoglobin, which is freely filtered by the kidneys and can cause tubular injury
Potassium and phosphate, which shift rapidly into the extracellular space
Creatine kinase and other muscle enzymes, which indicate the extent of muscle breakdown
Organic acids and metabolites that contribute to metabolic disturbance
As these substances accumulate, the kidneys become a major site of secondary injury. Myoglobin can precipitate within renal tubules, particularly in acidic or hypovolaemic states, impairing filtration and promoting acute kidney injury. At the same time, abrupt electrolyte shifts increase the risk of cardiac arrhythmias and neuromuscular dysfunction.
The clinical severity of rhabdomyolysis is determined not only by the amount of muscle damage but also by how quickly released contents are diluted, cleared, and excreted. Adequate circulating volume and renal perfusion are critical protective factors, while dehydration, acidosis, and delayed recognition markedly increase the risk of systemic complications.
Beyond the Basics
Energy failure and muscle cell necrosis
Skeletal muscle fibres depend on continuous adenosine triphosphate availability to maintain membrane integrity and ionic gradients. In rhabdomyolysis, ATP depletion occurs when metabolic demand exceeds supply, such as during prolonged exertion, ischaemia, hyperthermia, trauma, toxins, or severe metabolic stress. As ATP levels fall, calcium pumps fail and intracellular calcium accumulates.
Excess calcium activates proteolytic enzymes and phospholipases that degrade contractile proteins, cytoskeletal elements, and cell membranes. This initiates a self-amplifying cycle of injury, where membrane disruption worsens calcium influx and accelerates muscle fibre necrosis. The result is widespread muscle breakdown rather than isolated fibre damage.
Myoglobin release and renal injury
Myoglobin released from necrotic muscle enters the circulation and is freely filtered by the kidneys. Within the renal tubules, myoglobin can precipitate (clump), particularly in acidic urine, forming obstructive casts that impair tubular flow. Myoglobin also generates reactive oxygen species, exerting direct cytotoxic effects on tubular epithelial cells.
At the same time, large volumes of fluid shift into injured muscle, reducing circulating volume and renal perfusion. The combination of hypoperfusion, tubular obstruction, and oxidative injury explains why acute kidney injury is a defining and potentially early complication of rhabdomyolysis, even when muscle injury appears localised.
Electrolyte shifts and cardiac instability
Skeletal muscle contains the majority of the body’s intracellular potassium and phosphate. Rapid muscle breakdown releases these electrolytes into the extracellular space, producing hyperkalaemia and hyperphosphataemia. Hyperkalaemia alters myocardial membrane potentials and conduction velocity, creating immediate risk of arrhythmia.
As renal function declines, the ability to excrete excess electrolytes is reduced, amplifying these disturbances. Later in the disease course, hypocalcaemia may develop as calcium shifts into damaged muscle and complexes with phosphate. These evolving electrolyte changes contribute to neuromuscular dysfunction and cardiovascular instability.
Inflammatory cascade and systemic effects
Muscle necrosis triggers a systemic inflammatory response characterised by cytokine release and increased capillary permeability. Fluid leakage into interstitial spaces worsens hypovolaemia and reduces effective circulating volume. This further compromises renal perfusion and contributes to shock in severe cases.
Inflammation also promotes metabolic acidosis through lactic acid accumulation and reduced renal acid clearance. These systemic effects arise from widespread physiological stress rather than isolated muscle injury, explaining why rhabdomyolysis can progress rapidly to multi-organ dysfunction.
Compartment syndrome and secondary muscle injury
Severe muscle swelling within non-compliant fascial compartments raises intracompartmental pressure. As pressure exceeds capillary perfusion pressure, local blood flow is reduced, producing secondary ischaemia. Nerve conduction is impaired, and muscle necrosis accelerates.
This cycle of swelling, ischaemia, and cell death perpetuates rhabdomyolysis even after the initial insult has ceased. Delayed recognition allows irreversible muscle damage and long-term functional loss, illustrating how local mechanical factors amplify systemic metabolic injury.
Clinical Connections
Rhabdomyolysis has direct and predictable clinical consequences because the breakdown of skeletal muscle releases large intracellular contents into the circulation. Myoglobin, potassium, phosphate, creatine kinase and uric acid enter the bloodstream in quantities that exceed normal clearance capacity. Myoglobin is freely filtered at the glomerulus, but in acidic or hypovolaemic states it precipitates within renal tubules, causing obstruction and direct tubular toxicity. This explains why acute kidney injury is a central complication of rhabdomyolysis rather than a coincidental finding, and why reduced urine output is a late and concerning sign rather than an early symptom of muscle injury itself.
The systemic effects extend beyond the kidneys. Potassium released from damaged muscle cells can rise rapidly, predisposing to life-threatening cardiac arrhythmias, while phosphate release and secondary hypocalcaemia (reduced circulating calcium due to calcium shifting into damaged muscle) can contribute to neuromuscular irritability and seizures. Metabolic acidosis commonly develops as lactic acid and other organic acids accumulate, further worsening myoglobin precipitation within the kidneys. These complications mean that clinical deterioration may occur even when muscle pain is mild or improving.
Key clinical links that guide assessment and monitoring include:
Acute kidney injury, suggested by rising creatinine and falling urine output, driven by myoglobin-induced tubular injury
Hyperkalaemia, which explains ECG changes and arrhythmias rather than primary cardiac pathology
Hypocalcaemia in the early phase, causing muscle twitching or paraesthesia, with possible rebound hypercalcaemia during recovery
Diagnosis is established biochemically, most often by a markedly elevated creatine kinase level, typically more than five times the upper limit of normal, in the context of a compatible clinical trigger such as trauma, prolonged immobilisation, exertion, drug toxicity or heat injury. Urinalysis may show a positive blood result without red blood cells on microscopy, reflecting myoglobin rather than haematuria.
Management strategies such as early aggressive intravenous fluids target intravascular volume depletion and dilute nephrotoxic pigments, while urine alkalinisation may be considered to reduce myoglobin precipitation in selected cases. Continuous cardiac monitoring and serial electrolyte measurement are essential because complications arise from circulating muscle breakdown products, not from the local muscle injury itself.
Concept Check
How does ATP depletion lead to skeletal muscle cell necrosis?
Why does myoglobin cause renal tubular injury?
How does rhabdomyolysis lead to hyperkalaemia and cardiac risk?
Why does hypocalcaemia often develop later in the disease course?
How does muscle swelling contribute to ongoing tissue damage?